163 related articles for article (PubMed ID: 34426799)
21. SARS-CoV-2 antibody dynamics and B-cell memory response over time in COVID-19 convalescent subjects.
Achiron A; Gurevich M; Falb R; Dreyer-Alster S; Sonis P; Mandel M
Clin Microbiol Infect; 2021 Sep; 27(9):1349.e1-1349.e6. PubMed ID: 33975009
[TBL] [Abstract][Full Text] [Related]
22. Surface contamination by SARS-CoV2 RNA in dedicated COVID care area of a tertiary care hospital in North India.
Sarkar S; Ghosh A; Mohindra R; Thomas L; Yadav D; Kandpal HC; Biswal M; Lakshmi PVM; Suri V; Koushal V; Malhotra P; Ratho RK; Puri GD; Singh MP
Virusdisease; 2022 Sep; 33(3):236-243. PubMed ID: 35965883
[TBL] [Abstract][Full Text] [Related]
23. COVID-19-Associated Pneumonia in a B-Cell-Depleted Patient With Non-Hodgkin Lymphoma: Recovery With Hyperimmune Plasma.
Colombo D; Gatti A; Alabardi P; Bompane D; Bonardi G; Mumoli N; Faggioli P; Clerici P; Brando B; Mazzone A
J Hematol; 2022 Apr; 11(2):77-80. PubMed ID: 35573753
[TBL] [Abstract][Full Text] [Related]
24. Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases.
Nayak B; Lal G; Kumar S; Das CJ; Saraya A; Shalimar
Front Cell Infect Microbiol; 2021; 11():753249. PubMed ID: 34760721
[TBL] [Abstract][Full Text] [Related]
25. Multisystem inflammatory syndrome in neonates (MIS-N) associated with SARS-CoV2 infection: a case series.
More K; Aiyer S; Goti A; Parikh M; Sheikh S; Patel G; Kallem V; Soni R; Kumar P
Eur J Pediatr; 2022 May; 181(5):1883-1898. PubMed ID: 35031848
[TBL] [Abstract][Full Text] [Related]
26. Neutralizing SARS-CoV-2 Antibodies in Commercial Immunoglobulin Products Give Patients with X-Linked Agammaglobulinemia Limited Passive Immunity to the Omicron Variant.
Lindahl H; Klingström J; Da Silva Rodrigues R; Christ W; Chen P; Ljunggren HG; Buggert M; Aleman S; Smith CIE; Bergman P
J Clin Immunol; 2022 Aug; 42(6):1130-1136. PubMed ID: 35538387
[TBL] [Abstract][Full Text] [Related]
27. Antibody response to multiple antigens of SARS-CoV-2 in patients with diabetes: an observational cohort study.
Lampasona V; Secchi M; Scavini M; Bazzigaluppi E; Brigatti C; Marzinotto I; Davalli A; Caretto A; Laurenzi A; Martinenghi S; Molinari C; Vitali G; Di Filippo L; Mercalli A; Melzi R; Tresoldi C; Rovere-Querini P; Landoni G; Ciceri F; Bosi E; Piemonti L
Diabetologia; 2020 Dec; 63(12):2548-2558. PubMed ID: 33029657
[TBL] [Abstract][Full Text] [Related]
28. Severe acute myopathy following SARS-CoV-2 infection: a case report and review of recent literature.
Islam B; Ahmed M; Islam Z; Begum SM
Skelet Muscle; 2021 Apr; 11(1):10. PubMed ID: 33883014
[TBL] [Abstract][Full Text] [Related]
29. Immunologic memory to SARS-CoV-2 in convalescent COVID-19 patients at 1 year postinfection.
Hou H; Zhang Y; Tang G; Luo Y; Liu W; Cheng C; Jiang Y; Xiong Z; Wu S; Sun Z; Xu S; Fan X; Wang F
J Allergy Clin Immunol; 2021 Dec; 148(6):1481-1492.e2. PubMed ID: 34536418
[TBL] [Abstract][Full Text] [Related]
30. [Investigation of SARS-CoV-2-Specific Humoral and Cellular Immunity Values in Health Care Workers with COVID-19 Disease and Administered with COVID-19 Vaccine].
Keskin AÜ; Dalan AB; Çıragil P; Topkaya AE
Mikrobiyol Bul; 2022 Jul; 56(3):480-492. PubMed ID: 35960239
[TBL] [Abstract][Full Text] [Related]
31. Measurement of SARS-CoV-2-Specific Humoral and Cellular Immunity in Coronavirus Disease 2019 Convalescent Health Care Workers in Iraq.
Hasan Ali I; Sahib Abdulamir A
Arch Razi Inst; 2021 Nov; 76(5):1255-2127. PubMed ID: 35355770
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
Stratton CW; Tang YW; Lu H
J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
[TBL] [Abstract][Full Text] [Related]
33. Detectable SARS-CoV-2 viral RNA in feces of three children during recovery period of COVID-19 pneumonia.
Zhang T; Cui X; Zhao X; Wang J; Zheng J; Zheng G; Guo W; Cai C; He S; Xu Y
J Med Virol; 2020 Jul; 92(7):909-914. PubMed ID: 32222992
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal immune profiling reveals dominant epitopes mediating long-term humoral immunity in COVID-19-convalescent individuals.
Li M; Liu J; Lu R; Zhang Y; Du M; Xing M; Wu Z; Kong X; Zhu Y; Zhou X; Hu L; Zhang C; Zhou D; Jin X
J Allergy Clin Immunol; 2022 Apr; 149(4):1225-1241. PubMed ID: 35074422
[TBL] [Abstract][Full Text] [Related]
35. Erratum for Combined REGN-COV2 Antibody Therapy Immediately Prevented a Patient with Refractory Type 1 Autoimmune Pancreatitis from Contracting SARS-CoV-2 during the Sixth Wave in Japan.
Katsuo C; Kubota K; Tanaka K; Kurita Y; Nakajima A
Intern Med; 2023; 62(17):2595. PubMed ID: 37661419
[No Abstract] [Full Text] [Related]
36. Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern.
Falcone M; Tiseo G; Valoriani B; Barbieri C; Occhineri S; Mazzetti P; Vatteroni ML; Suardi LR; Riccardi N; Pistello M; Tacconi D; Menichetti F
Infect Dis Ther; 2021 Dec; 10(4):2479-2488. PubMed ID: 34435337
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
[TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 Neutralizing Antibodies for COVID-19 Prevention and Treatment.
Li D; Sempowski GD; Saunders KO; Acharya P; Haynes BF
Annu Rev Med; 2022 Jan; 73():1-16. PubMed ID: 34428080
[TBL] [Abstract][Full Text] [Related]
39. Casirivimab-Imdevimab (REGN-COV2) for Mild to Moderate SARS-CoV-2 Infection in Kidney Transplant Recipients.
Liu EC; Lee JH; Loo A; Mazur S; Sultan S; Aull M; Lee JB; Muthukumar T; Hartono C
Kidney Int Rep; 2021 Nov; 6(11):2900-2902. PubMed ID: 34514186
[No Abstract] [Full Text] [Related]
40. Casirivimab-Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19.
Razonable RR; Pawlowski C; O'Horo JC; Arndt LL; Arndt R; Bierle DM; Borgen MD; Hanson SN; Hedin MC; Lenehan P; Puranik A; Seville MT; Speicher LL; Tulledge-Scheitel SM; Venkatakrishnan AJ; Wilker CG; Badley AD; Ganesh R
EClinicalMedicine; 2021 Oct; 40():101102. PubMed ID: 34485873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
